다운로드 MyFibroScan PC 용

PC를 설정하고 Windows 11에서 MyFibroScan 앱을 다운로드하는 단계:

1. 컴퓨터가 호환되는지 확인: 최소 요구 사항은 다음과 같습니다.
• RAM: 8GB (최저한의), 16GB (추천)
• 저장: SSD
• Processor:
• Intel Core i3 8th Gen (최소 이상)
• AMD Ryzen 3000 (최소 이상)
• Qualcomm Snapdragon 8c (최소 이상)
• Processor Architecture: x64 or ARM64
2. MyFibroScan 에 이미 기본 Windows 버전이 있는지 확인하십시오. 여기서 하세요 ». 기본 버전이 없으면 3단계로 진행합니다.

FibroScan® is the non-invasive solution for comprehensive management of liver health. Fibroscan® provides unique and patented biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines. myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way : The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting Fibroscan® examination results. Scores enhance Fibroscan® liver disease assessment with biological markers. Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions. - Agile™3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins. - Agile™4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin. - Fast™ is an aid to identify at risk NASH patients defined as NASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast™.